{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:59:12Z","timestamp":1792425552597,"version":"4.5.0"},"reference-count":174,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing Municipal Natural Science Foundation","award":["7184252"],"award-info":[{"award-number":["7184252"]}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0530204"],"award-info":[{"award-number":["2024ZD0530204"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82571043"],"award-info":[{"award-number":["82571043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Physician-Scientist Training Program","award":["BJPSTP-2025-18"],"award-info":[{"award-number":["BJPSTP-2025-18"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2024IR36"],"award-info":[{"award-number":["2024IR36"]}]},{"name":"Chinese Cardiovascular Association-Natural lipid-lowering drugs fund","award":["2023-CCA-NLD-899"],"award-info":[{"award-number":["2023-CCA-NLD-899"]}]},{"name":"China Endocrine and Metabolism Young Scientific Talent Research Project","award":["2022-N-02-01"],"award-info":[{"award-number":["2022-N-02-01"]}]},{"name":"China Diabetes Young Scientific Talent Research Project"},{"name":"Bethune-Merck Diabetes Research Fund of Bethune Charitable Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Diabetic cardiomyopathy is a specific form of heart dysfunction that occurs in diabetic patients independent of other cardiomyopathies such as coronary artery disease. It significantly contributes to heart failure and mortality in this population. The pathogenesis of diabetic cardiomyopathy mainly includes oxidative stress, inflammatory response, apoptosis and disrupted mitochondrial homeostasis. Mitochondrial homeostasis, encompassing mitochondrial dynamics, mitochondrial oxidative metabolism and mitophagy, is regulated by a variety of signaling pathways and plays a pivotal role in maintaining the normal function of cardiomyocytes. At present, the exact mechanisms underlying diabetic cardiomyopathy pathogenesis remain unclear, and effective prevention and treatment methods are lacking. This review therefore expounds the pathogenesis of diabetic cardiomyopathy from the perspective of mitochondrial homeostasis, providing new approaches to clinical management.<\/jats:p>","DOI":"10.3390\/antiox15030399","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:07:06Z","timestamp":1774271226000},"page":"399","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mitochondrial Homeostasis in Diabetic Cardiomyopathy: From Dysfunction to Therapeutic Strategies"],"prefix":"10.3390","volume":"15","author":[{"given":"Yafei","family":"Huang","sequence":"first","affiliation":[{"name":"Research Center, Peking University First Hospital, Beijing 100034, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital, Beijing 100034, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xindi","family":"Jiang","sequence":"additional","affiliation":[{"name":"Research Center, Peking University First Hospital, Beijing 100034, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China"},{"name":"Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zheng","sequence":"additional","affiliation":[{"name":"Research Center, Peking University First Hospital, Beijing 100034, China"},{"name":"Department of Endocrinology, Peking University First Hospital, Beijing 100034, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Liu, L., Zhang, J., Cheng, Y., Zhu, M., Xiao, Z., Ruan, G., and Wei, Y. (2022). Gut microbiota: A new target for T2DM prevention and treatment. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.958218"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.beem.2016.05.003","article-title":"Type 2 diabetes: A 21st century epidemic","volume":"30","author":"Jaacks","year":"2016","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2014). Diagnosis and classification of diabetes mellitus. Diabetes Care, 37, S81\u2013S90.","DOI":"10.2337\/dc14-S081"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.atherosclerosis.2018.05.042","article-title":"Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver","volume":"275","author":"Sung","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2522\/ptj.20080020","article-title":"Epidemiology of diabetes and diabetes-related complications","volume":"88","author":"Deshpande","year":"2008","journal-title":"Phys. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1573403X1604201229115531","article-title":"Complications of the Type 2 Diabetes Mellitus","volume":"16","author":"Farmaki","year":"2020","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S2213-8587(19)30026-9","article-title":"The obesity transition: Stages of the global epidemic","volume":"7","author":"Jaacks","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","article-title":"The burden and risks of emerging complications of diabetes mellitus","volume":"18","author":"Tomic","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lu, Y., Lu, Y., Meng, J., and Wang, Z. (2021). Pyroptosis and Its Regulation in Diabetic Cardiomyopathy. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.791848"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.hfc.2019.02.003","article-title":"Diabetic Cardiomyopathy: Definition, Diagnosis, and Therapeutic Implications","volume":"15","author":"Paolillo","year":"2019","journal-title":"Heart Fail. Clin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4070\/kcj.2015.45.4.266","article-title":"Diabetic Cardiomyopathy; Summary of 41 Years","volume":"45","author":"Yilmaz","year":"2015","journal-title":"Korean Circ. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"107920","DOI":"10.1016\/j.pharmthera.2021.107920","article-title":"Cellular mechanisms and recommended drug-based therapeutic options in diabetic cardiomyopathy","volume":"228","author":"Dannenberg","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-019-0213-9","article-title":"Targeting innate immune mediators in type 1 and type 2 diabetes","volume":"19","author":"Donath","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart Failure in Type 2 Diabetes Mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12933-023-01941-1","article-title":"Endothelial MICU1 alleviates diabetic cardiomyopathy by attenuating nitrative stress-mediated cardiac microvascular injury","volume":"22","author":"Shi","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Batista, J.P.T., Faria, A.O.V., Ribeiro, T.F.S., and Sim\u00f5es, E.S.A.C. (2023). The Role of Renin-Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review. Life, 13.","DOI":"10.3390\/life13071598"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Rinaldi, L., Coviello, F., Di Martino, A., Albanese, G., Colantuoni, S., and Medicamento, G. (2022). Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes. Biomolecules, 12.","DOI":"10.3390\/biom12020176"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Vasileiou, P.V.S., Evangelou, K., Vlasis, K., Fildisis, G., Panayiotidis, M.I., Chronopoulos, E., Passias, P.G., Kouloukoussa, M., Gorgoulis, V.G., and Havaki, S. (2019). Mitochondrial Homeostasis and Cellular Senescence. Cells, 8.","DOI":"10.3390\/cells8070686"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s44194-024-00032-x","article-title":"Mitochondrial homeostasis: Shaping health and disease","volume":"3","author":"Li","year":"2024","journal-title":"Curr. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e58041","DOI":"10.7554\/eLife.58041","article-title":"Mitochondrial fatty acid synthesis coordinates oxidative metabolism in mammalian mitochondria","volume":"9","author":"Nowinski","year":"2020","journal-title":"eLife"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Chandel","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"101674","DOI":"10.1016\/j.redox.2020.101674","article-title":"Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement","volume":"37","author":"Braganza","year":"2020","journal-title":"Redox Biol."},{"key":"ref_27","first-page":"3","article-title":"Mitochondrial electron transport chain, ROS generation and uncoupling (Review)","volume":"44","author":"Zhao","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopha.2015.07.025","article-title":"Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight","volume":"74","author":"Bhat","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: Mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm3984","article-title":"New roles for mitochondrial proteases in health, ageing and disease","volume":"16","author":"Langer","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","article-title":"Mitochondrial dynamics in health and disease: Mechanisms and potential targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e21620","DOI":"10.1096\/fj.202100067R","article-title":"Mitochondrial fusion and fission: The fine-tune balance for cellular homeostasis","volume":"35","author":"Adebayo","year":"2021","journal-title":"FASEB J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/13014","article-title":"The dynamin-related GTPase Dnm1 regulates mitochondrial fission in yeast","volume":"1","author":"Bleazard","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e11553","DOI":"10.7554\/eLife.11553","article-title":"Actin filaments target the oligomeric maturation of the dynamin GTPase Drp1 to mitochondrial fission sites","volume":"4","author":"Ji","year":"2015","journal-title":"eLife"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1091\/mbc.e12-10-0721","article-title":"Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission","volume":"24","author":"Song","year":"2013","journal-title":"Mol. Biol. Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1083\/jcb.201007152","article-title":"Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells","volume":"191","author":"Otera","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/15548627.2025.2552900","article-title":"PPA2 activates MTFP1-DNM1L fission signaling to govern mitochondrial proliferation and mitophagy","volume":"22","author":"Mishra","year":"2026","journal-title":"Autophagy"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1016\/j.cell.2024.05.017","article-title":"MTFP1 controls mitochondrial fusion to regulate inner membrane quality control and maintain mtDNA levels","volume":"187","author":"Burr","year":"2024","journal-title":"Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/EBC20170104","article-title":"Mitochondrial dynamics: Overview of molecular mechanisms","volume":"62","author":"Tilokani","year":"2018","journal-title":"Essays Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2006.06.010","article-title":"Mitochondria: Dynamic organelles in disease, aging, and development","volume":"125","author":"Chan","year":"2006","journal-title":"Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1099793","article-title":"Structural basis of mitochondrial tethering by mitofusin complexes","volume":"305","author":"Koshiba","year":"2004","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature21077","article-title":"MFN1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion","volume":"542","author":"Cao","year":"2017","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"18792","DOI":"10.1074\/jbc.M400920200","article-title":"Loss of the intermembrane space protein Mgm1\/OPA1 induces swelling and localized constrictions along the lengths of mitochondria","volume":"279","author":"Griparic","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41586-025-08590-2","article-title":"Dual regulation of mitochondrial fusion by Parkin-PINK1 and OMA1","volume":"639","author":"Yamada","year":"2025","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.celrep.2017.08.087","article-title":"Parkin-Independent Mitophagy Controls Chemotherapeutic Response in Cancer Cells","volume":"20","author":"Villa","year":"2017","journal-title":"Cell Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1083\/jcb.200910140","article-title":"PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy","volume":"189","author":"Matsuda","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nature13392","article-title":"Ubiquitin is phosphorylated by PINK1 to activate parkin","volume":"510","author":"Koyano","year":"2014","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ncb2012","article-title":"PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1","volume":"12","author":"Geisler","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"ref_49","first-page":"282","article-title":"Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control","volume":"33","author":"McLelland","year":"2014","journal-title":"EMBO J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"19500","DOI":"10.1073\/pnas.0708818104","article-title":"NIX is required for programmed mitochondrial clearance during reticulocyte maturation","volume":"104","author":"Schweers","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41419-022-04795-9","article-title":"BNIP3 (BCL2 interacting protein 3) regulates pluripotency by modulating mitochondrial homeostasis via mitophagy","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4161\/auto.7.3.14509","article-title":"Autophagy receptors in developmental clearance of mitochondria","volume":"7","author":"Novak","year":"2011","journal-title":"Autophagy"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.molcel.2014.02.034","article-title":"A regulatory signaling loop comprising the PGAM5 phosphatase and CK2 controls receptor-mediated mitophagy","volume":"54","author":"Chen","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Liu, L., Li, Y., and Chen, Q. (2021). The Emerging Role of FUNDC1-Mediated Mitophagy in Cardiovascular Diseases. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.807654"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"495","DOI":"10.15252\/embr.201643309","article-title":"Mitochondrial E3 ligase MARCH5 regulates FUNDC1 to fine-tune hypoxic mitophagy","volume":"18","author":"Chen","year":"2017","journal-title":"EMBO Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"102549","DOI":"10.1016\/j.arr.2024.102549","article-title":"Mitochondria break free: Mitochondria-derived vesicles in aging and associated conditions","volume":"102","author":"Ferrucci","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41556-021-00798-4","article-title":"MIROs and DRP1 drive mitochondrial-derived vesicle biogenesis and promote quality control","volume":"23","author":"Nolte","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2023.11.014","article-title":"Mitochondrial-derived vesicles in metabolism, disease, and aging","volume":"36","author":"McBride","year":"2024","journal-title":"Cell Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e102539","DOI":"10.15252\/embj.2019102539","article-title":"Tollip coordinates Parkin-dependent trafficking of mitochondrial-derived vesicles","volume":"39","author":"Ryan","year":"2020","journal-title":"EMBO J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.freeradbiomed.2022.06.233","article-title":"Mitochondrial-derived vesicles: Gatekeepers of mitochondrial response to oxidative stress","volume":"188","author":"Peng","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2337\/db07-0481","article-title":"Mitochondrial energetics in the heart in obesity-related diabetes: Direct evidence for increased uncoupled respiration and activation of uncoupling proteins","volume":"56","author":"Boudina","year":"2007","journal-title":"Diabetes"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.2337\/db16-1237","article-title":"MICU1 Alleviates Diabetic Cardiomyopathy Through Mitochondrial Ca(2+)-Dependent Antioxidant Response","volume":"66","author":"Ji","year":"2017","journal-title":"Diabetes"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"C1005","DOI":"10.1152\/ajpcell.00236.2016","article-title":"Expression of the mitochondrial calcium uniporter in cardiac myocytes improves impaired mitochondrial calcium handling and metabolism in simulated hyperglycemia","volume":"311","author":"Suarez","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Parker, A.M., Tate, M., Prakoso, D., Deo, M., Willis, A.M., Nash, D.M., Donner, D.G., Crawford, S., Kiriazis, H., and Granata, C. (2021). Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.672252"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e13388","DOI":"10.14814\/phy2.13388","article-title":"Alterations in fatty acid metabolism and sirtuin signaling characterize early type-2 diabetic hearts of fructose-fed rats","volume":"5","author":"Lou","year":"2017","journal-title":"Physiol. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/db19-1057","article-title":"Maintaining Myocardial Glucose Utilization in Diabetic Cardiomyopathy Accelerates Mitochondrial Dysfunction","volume":"69","author":"Wende","year":"2020","journal-title":"Diabetes"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2020.11.033","article-title":"Temporal evolution of cardiac mitochondrial dysfunction in a type 1 diabetes model. Mitochondrial complex I impairment, and H(2)O(2) and NO productions as early subcellular events","volume":"162","author":"Rey","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"174081","DOI":"10.1016\/j.ejphar.2021.174081","article-title":"Endogenous asymmetric dimethylarginine accumulation precipitates the cardiac and mitochondrial dysfunctions in type 1 diabetic rats","volume":"902","author":"Xiong","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.7150\/thno.33684","article-title":"Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy","volume":"9","author":"Hu","year":"2019","journal-title":"Theranostics"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41419-021-03502-4","article-title":"High glucose induces Drp1-mediated mitochondrial fission via the Orai1 calcium channel to participate in diabetic cardiomyocyte hypertrophy","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Feng, X., Wang, S., Yang, X., Lin, J., Man, W., Dong, Y., Zhang, Y., Zhao, Z., Wang, H., and Sun, D. (2020). Mst1 Knockout Alleviates Mitochondrial Fission and Mitigates Left Ventricular Remodeling in the Development of Diabetic Cardiomyopathy. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.628842"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/CIRCRESAHA.117.311307","article-title":"Mitochondrial Reactive Oxygen Species in Lipotoxic Hearts Induce Post-Translational Modifications of AKAP121, DRP1, and OPA1 That Promote Mitochondrial Fission","volume":"122","author":"Tsushima","year":"2018","journal-title":"Circ. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.bbadis.2018.04.009","article-title":"Mst1 inhibits Sirt3 expression and contributes to diabetic cardiomyopathy through inhibiting Parkin-dependent mitophagy","volume":"1865","author":"Wang","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.bbadis.2016.10.021","article-title":"Sirt3 deficiency exacerbates diabetic cardiac dysfunction: Role of Foxo3A-Parkin-mediated mitophagy","volume":"1863","author":"Yu","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1161\/CIRCRESAHA.118.314607","article-title":"Mitophagy Is Essential for Maintaining Cardiac Function During High Fat Diet-Induced Diabetic Cardiomyopathy","volume":"124","author":"Tong","year":"2019","journal-title":"Circ. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2020.09.003","article-title":"BRD4 inhibition by JQ1 prevents high-fat diet-induced diabetic cardiomyopathy by activating PINK1\/Parkin-mediated mitophagy in vivo","volume":"149","author":"Mu","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1111\/bph.14431","article-title":"Mitochondrial function in the heart: The insight into mechanisms and therapeutic potentials","volume":"176","author":"Nguyen","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00395-020-00835-7","article-title":"Reduced reticulum-mitochondria Ca(2+) transfer is an early and reversible trigger of mitochondrial dysfunctions in diabetic cardiomyopathy","volume":"115","author":"Dia","year":"2020","journal-title":"Basic Res. Cardiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00424-021-02650-y","article-title":"Ca(2+) mishandling and mitochondrial dysfunction: A converging road to prediabetic and diabetic cardiomyopathy","volume":"474","author":"Palomeque","year":"2022","journal-title":"Pflug. Arch."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/HYPERTENSIONAHA.118.11035","article-title":"Potential Protective Mechanism in the Cardiac Microvascular Injury","volume":"72","author":"Li","year":"2018","journal-title":"Hypertension"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCHEARTFAILURE.111.961565","article-title":"p53 promotes cardiac dysfunction in diabetic mellitus caused by excessive mitochondrial respiration-mediated reactive oxygen species generation and lipid accumulation","volume":"5","author":"Nakamura","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/ars.2017.7415","article-title":"Mitochondrial NAD(+)\/NADH Redox State and Diabetic Cardiomyopathy","volume":"30","author":"Berthiaume","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac Energy Metabolism in Heart Failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s00125-020-05103-w","article-title":"Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis","volume":"63","author":"Qi","year":"2020","journal-title":"Diabetologia"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-physiol-021317-121427","article-title":"The Role of Autophagy in the Heart","volume":"80","author":"Sciarretta","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"ref_86","first-page":"2575","article-title":"Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular Aging","volume":"16","author":"Zhang","year":"2024","journal-title":"Aging Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"82","DOI":"10.31083\/j.rcm2403082","article-title":"Metabolic Changes in Cardiac Aging","volume":"24","author":"Hao","year":"2023","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Patyal, P., Azhar, G., Verma, A., Sharma, S., Shrivastava, J., Abdi, S.A.H., Zhang, X., and Wei, J.Y. (2025). Mitochondrial Dynamics in Aging Heart. Biomedicines, 13.","DOI":"10.3390\/biomedicines13112603"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12933-024-02357-1","article-title":"Mitochondrial network remodeling of the diabetic heart: Implications to ischemia related cardiac dysfunction","volume":"23","author":"Rudokas","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12967-023-03928-8","article-title":"Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: New insights from bioinformatics analysis","volume":"21","author":"Peng","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20517\/jca.2022.42","article-title":"The dynamic interplay between cardiac mitochondrial health and myocardial structural remodeling in metabolic heart disease, aging, and heart failure","volume":"3","author":"Werbner","year":"2023","journal-title":"J. Cardiovasc. Aging"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.mito.2019.06.002","article-title":"Mitochondrial dynamics and their potential as a therapeutic target","volume":"49","author":"Whitley","year":"2019","journal-title":"Mitochondrion"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Dai, W., and Jiang, L. (2019). Dysregulated Mitochondrial Dynamics and Metabolism in Obesity, Diabetes, and Cancer. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00570"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Lin, J., Duan, J., Wang, Q., Xu, S., Zhou, S., and Yao, K. (2022). Mitochondrial Dynamics and Mitophagy in Cardiometabolic Disease. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.917135"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e12491","DOI":"10.1111\/jpi.12491","article-title":"Melatonin prevents Drp1-mediated mitochondrial fission in diabetic hearts through SIRT1-PGC1\u03b1 pathway","volume":"65","author":"Ding","year":"2018","journal-title":"J. Pineal Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"113853","DOI":"10.1016\/j.jep.2021.113853","article-title":"Ophiopogonin D alleviates diabetic myocardial injuries by regulating mitochondrial dynamics","volume":"271","author":"Li","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Zhang, T., Li, Z., Xu, Y., Xu, C., Wang, H., and Rui, T. (2025). Regulation of mitochondrial dynamics in cardiomyocytes: Implications for cardiac health and disease. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1652683"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"4","DOI":"10.20517\/jca.2024.17","article-title":"Aging triggers mitochondrial, endoplasmic reticulum, and metabolic stress responses in the heart","volume":"5","author":"Muthu","year":"2025","journal-title":"J. Cardiovasc. Aging"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.7150\/ijms.98065","article-title":"Modulating mitochondrial dynamics ameliorates left ventricular dysfunction by suppressing diverse cell death pathways after diabetic cardiomyopathy","volume":"21","author":"Zhi","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/HYPERTENSIONAHA.120.15558","article-title":"Ca2+-Dependent NOX5 (NADPH Oxidase 5) Exaggerates Cardiac Hypertrophy Through Reactive Oxygen Species Production","volume":"76","author":"Zhao","year":"2020","journal-title":"Hypertension"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Zheng, H., Zhu, H., Liu, X., Huang, X., Huang, A., and Huang, Y. (2021). Mitophagy in Diabetic Cardiomyopathy: Roles and Mechanisms. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.750382"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7150\/ijbs.29680","article-title":"Metformin Inhibits the NLRP3 Inflammasome via AMPK\/mTOR-Dependent Effects in Diabetic Cardiomyopathy","volume":"15","author":"Yang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2020.04.015","article-title":"Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation","volume":"32","author":"Bharath","year":"2020","journal-title":"Cell Metab."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Bai, J., Liu, C., Zhu, P., and Li, Y. (2020). Novel Insights Into Molecular Mechanism of Mitochondria in Diabetic Cardiomyopathy. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.609157"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1002\/jcp.27597","article-title":"Mitochondrial quality control in cardiac cells: Mechanisms and role in cardiac cell injury and disease","volume":"234","author":"Tahrir","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2531458","DOI":"10.1155\/2022\/2531458","article-title":"Mitochondria-Endoplasmic Reticulum Contacts: The Promising Regulators in Diabetic Cardiomyopathy","volume":"2022","author":"Chen","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"100822","DOI":"10.1016\/j.mam.2019.09.006","article-title":"Emerging role of mitophagy in cardiovascular physiology and pathology","volume":"71","author":"Morales","year":"2020","journal-title":"Mol. Asp. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00395-023-01009-x","article-title":"Mitophagy for cardioprotection","volume":"118","author":"Titus","year":"2023","journal-title":"Basic. Res. Cardiol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Zhou, R., Zhang, Z., Li, X., Duan, Q., Miao, Y., Zhang, T., Wang, M., Li, J., Zhang, W., and Wang, L. (2025). Autophagy in High-Fat Diet and Streptozotocin-Induced Metabolic Cardiomyopathy: Mechanisms and Therapeutic Implications. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26041668"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"103010","DOI":"10.1016\/j.redox.2023.103010","article-title":"Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress","volume":"69","author":"Cai","year":"2024","journal-title":"Redox Biol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1111\/jcmm.16601","article-title":"Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPK\u03b1\/TGF-\u03b2\/Smad signalling in type 2 diabetic rats","volume":"25","author":"Tian","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Yang, C., Xiao, C., Ding, Z., Zhai, X., Liu, J., and Yu, M. (2024). Canagliflozin Mitigates Diabetic Cardiomyopathy Through Enhanced PINK1-Parkin Mitophagy. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25137008"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Zhang, X., Meng, L., Gong, M., Li, J., Shi, W., Qiu, J., Yang, Y., Zhao, J., and Suo, Y. (2021). Pioglitazone Inhibits Diabetes-Induced Atrial Mitochondrial Oxidative Stress and Improves Mitochondrial Biogenesis, Dynamics, and Function Through the PPAR-\u03b3\/PGC-1\u03b1 Signaling Pathway. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.658362"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"171429","DOI":"10.1016\/j.peptides.2025.171429","article-title":"Liraglutide suppresses ferroptosis by upregulation NRF2 in type 2 diabetic cardiomyopathy","volume":"192","author":"Chen","year":"2025","journal-title":"Peptides"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2147\/DDDT.S400249","article-title":"Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p\/SLMAP","volume":"17","author":"Fang","year":"2023","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_116","first-page":"520","article-title":"[Exendin-4 alleviates diabetic cardiomyopathy in mice by regulating Sirt1\/PGC1\u03b1]","volume":"38","author":"Cai","year":"2018","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13098-023-01064-3","article-title":"Finerenone attenuates myocardial apoptosis, metabolic disturbance and myocardial fibrosis in type 2 diabetes mellitus","volume":"15","author":"Jin","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40200-025-01677-7","article-title":"Eplerenone alleviates diabetic cardiomyopathy by modulating ER stress, oxidative stress, and NLRP3 inflammasome activation","volume":"24","author":"Yaghooti","year":"2025","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"9232065","DOI":"10.1155\/2018\/9232065","article-title":"Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats","volume":"2018","author":"Liu","year":"2018","journal-title":"J. Diabetes Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"116552","DOI":"10.1016\/j.bcp.2024.116552","article-title":"Exendin-4 exhibits cardioprotective effects against high glucose-induced mitochondrial abnormalities: Potential role of GLP-1 receptor and mTOR signaling","volume":"229","author":"Parichatikanond","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4330\/wjc.v14.i4.220","article-title":"GRK5 is an essential co-repressor of the cardiac mineralocorticoid receptor and is selectively induced by finerenone","volume":"14","author":"Pollard","year":"2022","journal-title":"World J. Cardiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2217287","DOI":"10.1080\/0886022X.2023.2217287","article-title":"Comparative safety of sodium-glucose co-transporter 2 inhibitors in elderly patients with type 2 diabetes mellitus and diabetic kidney disease: A systematic review and meta-analysis","volume":"45","author":"Liu","year":"2023","journal-title":"Ren. Fail."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/jcp.30621","article-title":"Renoprotective mechanisms of sodium-glucose co-transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease","volume":"237","author":"Ravindran","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"108330","DOI":"10.1016\/j.pharmthera.2022.108330","article-title":"Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease","volume":"242","author":"Solomon","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/cvr\/cvae047","article-title":"SGLT2 inhibitors: From glucose-lowering to cardiovascular benefits","volume":"120","author":"Preda","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"C328","DOI":"10.1152\/ajpcell.00275.2019","article-title":"Cardioprotection conferred by sodium-glucose cotransporter 2 inhibitors: A renal proximal tubule perspective","volume":"318","author":"Polidoro","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11033-025-10260-5","article-title":"Empagliflozin in diabetic cardiomyopathy: Elucidating mechanisms, therapeutic potentials, and future directions","volume":"52","author":"Jaiswal","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","article-title":"SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart","volume":"18","author":"Li","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Trang, N.N., Chung, C.C., Lee, T.W., Cheng, W.L., Kao, Y.H., Huang, S.Y., Lee, T.I., and Chen, Y.J. (2021). Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031177"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"123819","DOI":"10.1016\/j.lfs.2025.123819","article-title":"Dapagliflozin attenuates diabetic cardiomyopathy via NRF2 protein upregulation-driven glutathione synthesis to inhibit myocardial ferroptosis","volume":"378","author":"Chen","year":"2025","journal-title":"Life Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1248\/bpb.b22-00289","article-title":"The Role of SGLT2 Inhibitor Ipragliflozin on Cardiac Hypertrophy and microRNA Expression Profiles in a Non-diabetic Rat Model of Cardiomyopathy","volume":"45","author":"Takasu","year":"2022","journal-title":"Biol. Pharm. Bull."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jare.2024.04.030","article-title":"Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expression","volume":"70","author":"Zhao","year":"2025","journal-title":"J. Adv. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"10742484251323428","DOI":"10.1177\/10742484251323428","article-title":"Direct Cardiac Mechanisms of the Sodium Glucose Co-Transporter 2 Inhibitor Class","volume":"30","author":"Hopkins","year":"2025","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1080\/07853890.2020.1841281","article-title":"The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection","volume":"53","author":"Brown","year":"2021","journal-title":"Ann. Med."},{"key":"ref_135","first-page":"100296","article-title":"SGLT2 inhibitor upregulates myocardial genes for oxidative phosphorylation and fatty acid metabolism in G\u03b1q-mice","volume":"12","author":"Chambers","year":"2025","journal-title":"J. Mol. Cell. Cardiol. Plus"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Dabravolski, S.A., Zhuravlev, A.D., Kartuesov, A.G., Borisov, E.E., Sukhorukov, V.N., and Orekhov, A.N. (2022). Mitochondria-Mediated Cardiovascular Benefits of Sodium-Glucose Co-Transporter 2 Inhibitors. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105371"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.bbrc.2018.11.135","article-title":"Lixisenatide enhances mitochondrial biogenesis and function through regulating the CREB\/PGC-1\u03b1 pathway","volume":"508","author":"Zhao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00395-024-01067-9","article-title":"Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2","volume":"119","author":"Chen","year":"2024","journal-title":"Basic Res. Cardiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/CIRCRESAHA.117.311588","article-title":"Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors","volume":"122","author":"Scheen","year":"2018","journal-title":"Circ. Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.119.042375","article-title":"Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial","volume":"140","author":"Verma","year":"2019","journal-title":"Circulation"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/eurheartj\/ehac693","article-title":"Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: The EMPEROR-Preserved trial","volume":"44","author":"Bhm","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2217\/fca-2023-0016","article-title":"Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice","volume":"19","author":"Formiga","year":"2023","journal-title":"Future Cardiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Boshchenko, A.A., Maslov, L.N., Mukhomedzyanov, A.V., Zhuravleva, O.A., Slidnevskaya, A.S., Naryzhnaya, N.V., Zinovieva, A.S., and Ilinykh, P.A. (2024). Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25094900"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e026728","DOI":"10.1161\/JAHA.122.026728","article-title":"Long-Term Activation of Glucagon-like peptide-1 receptor by Dulaglutide Prevents Diabetic Heart Failure and Metabolic Remodeling in Type 2 Diabetes","volume":"11","author":"Xie","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Pandey, S., Mangmool, S., and Parichatikanond, W. (2023). Multifaceted Roles of GLP-1 and Its Analogs: A Review on Molecular Mechanisms with a Cardiotherapeutic Perspective. Pharmaceuticals, 16.","DOI":"10.3390\/ph16060836"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"8640","DOI":"10.18632\/aging.103181","article-title":"Exenatide inhibits NF-\u03baB and attenuates ER stress in diabetic cardiomyocyte models","volume":"12","author":"Fu","year":"2020","journal-title":"Aging"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/FJC.0000000000001218","article-title":"A Glucagon-like Peptide 1 Analog Protects Mitochondria and Attenuates Hypoxia-Reoxygenation Injury in Cultured Cardiomyocytes","volume":"79","author":"Kobara","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/cvr\/cvz002","article-title":"The intestine responds to heart failure by enhanced mitochondrial fusion through glucagon-like peptide-1 signalling","volume":"115","author":"Naruse","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2024.5436","article-title":"New insight for SS-31 in treating diabetic cardiomyopathy: Activation of mitoGPX4 and alleviation of mitochondria-dependent ferroptosis","volume":"54","author":"Xiong","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"ref_153","first-page":"2461","article-title":"[Fucoidan sulfate regulates Hmox1-mediated ferroptosis to ameliorate myocardial injury in diabetic cardiomyopathy]","volume":"50","author":"Cai","year":"2025","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s12012-025-09992-4","article-title":"MiR214-3p Ameliorates Diabetic Cardiomyopathy by Inhibiting Ferroptosis","volume":"25","author":"Chen","year":"2025","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.apsb.2021.10.005","article-title":"Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK\/NRF2 pathways","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"3027514","DOI":"10.1155\/2022\/3027514","article-title":"6-Gingerol Alleviates Ferroptosis and Inflammation of Diabetic Cardiomyopathy via the Nrf2\/HO-1 Pathway","volume":"2022","author":"Wu","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"177032","DOI":"10.1016\/j.ejphar.2024.177032","article-title":"Phloridzin prevents diabetic cardiomyopathy by reducing inflammation and oxidative stress","volume":"984","author":"Xie","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.124.070279","article-title":"METTL3 Is Essential for Exercise Benefits in Diabetic Cardiomyopathy","volume":"152","author":"Wang","year":"2025","journal-title":"Circulation"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.123.065546","article-title":"AGO2 Protects Against Diabetic Cardiomyopathy by Activating Mitochondrial Gene Translation","volume":"149","author":"Zhan","year":"2024","journal-title":"Circulation"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.122.059631","article-title":"FGF21-Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity","volume":"146","author":"Jin","year":"2022","journal-title":"Circulation"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13105-018-0648-7","article-title":"Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats","volume":"75","author":"Diao","year":"2019","journal-title":"J. Physiol. Biochem."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/0973-1296.131031","article-title":"Protective effect and mechanism of Ginkgo biloba extract-EGb 761 on STZ-induced diabetic cardiomyopathy in rats","volume":"10","author":"Saini","year":"2014","journal-title":"Pharmacogn. Mag."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12933-018-0803-z","article-title":"Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits","volume":"17","author":"Zhang","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"115179","DOI":"10.1016\/j.bcp.2022.115179","article-title":"Alpha-lipoic acid treatment improves adverse cardiac remodelling in the diabetic heart\u2014The role of cardiac hydrogen sulfide-synthesizing enzymes","volume":"203","author":"Dugbartey","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Zhang, B., Zhang, J., Zhang, C., Zhang, X., Ye, J., Kuang, S., Sun, G., and Sun, X. (2018). Notoginsenoside R1 Protects Against Diabetic Cardiomyopathy Through Activating Estrogen Receptor \u03b1 and Its Downstream Signaling. Front. Pharmacol., 9, Erratum in Front. Pharmacol. 2025, 15, 1488083.","DOI":"10.3389\/fphar.2024.1488083"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Sadraei, S., Aarabi, A., Rajai Firouzabadi, S., Alinejadfard, M., Mohammadi, I., and Jolfayi, A.G. (2025). Cardiovascular benefits of semaglutide: A systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc. Disord., 25.","DOI":"10.1186\/s12872-025-05278-3"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/d41586-023-02528-2","article-title":"Anti-obesity drug also protects against heart disease-what happens next?","volume":"620","author":"Lenharo","year":"2023","journal-title":"Nature"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Kolkhof, P., Lawatscheck, R., Filippatos, G., and Bakris, G.L. (2022). Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone-Translational Aspects and Clinical Perspectives Across Multiple Organ Systems. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169243"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/bph.17327","article-title":"Semaglutide protects against diabetes-associated cardiac inflammation via Sirt3-dependent RKIP pathway","volume":"182","author":"Lin","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12967-016-0849-1","article-title":"Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy","volume":"14","author":"Zhang","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13098-024-01466-x","article-title":"Therapeutic potential of finerenone for diabetic cardiomyopathy: Focus on the mechanisms","volume":"16","author":"Wang","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.bbadis.2016.10.025","article-title":"Role of mineralocorticoid receptor activation in cardiac diastolic dysfunction","volume":"1863","author":"Jia","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jacc.2024.04.053","article-title":"Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial","volume":"84","author":"Batista","year":"2024","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/3\/399\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:54:02Z","timestamp":1774331642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/3\/399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,22]]},"references-count":174,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["antiox15030399"],"URL":"https:\/\/doi.org\/10.3390\/antiox15030399","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,22]]}}}